Page 38

Mayo_2017

ARTÍCULO DE INVESTIGACIÓN Estudios de imágenes en cáncer de próstata - N. Martínez et al Agradecimientos: Se realiza un agradecimiento al departamento de Anatomía Patológica Clínica Las Condes por la excelente disposición por contribuir 584 al desarrollo de esta investigación. Referencias 1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300. 2. Guía Clínica 2010 Cáncer de Próstata en personas de 15 años y más, Ministerio de Salud de Chile. Disponible en: http://www.supersalud.gob.cl/difusion/572/articles 650_guia_clinica.pdf. Consultado el 12 de junio de 2016. 3. DEIS (Departamento de estadísticas e información de salud). Tasa de Tumores Malignos según Sexo, Chile 1997-2013. Disponible en: http://www.deis.cl/ series-y-graficos-de-mortalidad Consultado el 12 de junio de 2016. 4. Besa P, Rosso R, Bustos M, Borghero Y, Trucco C, Mac-Namara M. Tratamiento del cáncer de próstata con radioterapia por modulación de intensidad, primera experiencia en Chile. Rev Med Chile 2011; 139 (11): 1451-7. 5. Mottet N, Bellmunt J, Briers E, van den Bergh R, Bolla M, van Casteren N, et al. Guidelines on Prostate Cancer. European Association of Urology 2015. Disponible: http://uroweb.org/wp-content/uploads/09-Prostate Cancer_LR.pdf. Consultado el 12 de junio de 2016. 6. Greene KL, Albertsen PC, Babaian RJ, Carter H, Gann P, Han M, et al. Prostate specific antigen best practice statement: 2009 update. J Urol 2009; 182: 2232-41. 7. Mohler J, Armstrong A, Bahnson RR, D’Amico A, Davis B, Eastham J, et al. NCCN Clinical Practice Guidelines in Oncology: Prostate cancer. Version 3. 2016. Disponible: https://www.nccn.org/professionals/physician_gls/ pdf/prostate.pdf Consultado el 12 de junio de 2016. 8. Gleave M,  Coupland D,  Drachenberg D,  Cohen L,  Kwong S,  Goldenberg SL, et al. Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer. Urology 1996; 47 (5): 708-12. 9. Narayan P,  Fournier G,  Gajendran V,  Leidich R,  Lo R, Wolf JS Jr, et al. Utility of preoperative serum prostate specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer. Urology 1994; 44 (4): 519-24. 10. Briganti A, Passoni N, Ferrari M, Capitanio U, Suardi N, Gallina A, et al. When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available. Guidelines and Proposal of a Novel Risk Stratification Tool. Eur Urol 2010; 57 (4): 551-8. 11. TNM Classification of Malignant Tumors, 7th edition, 2013. Union for International Cancer Control. Disponible:. www.iucc.org 12. Eifler JB, Feng Z, Lin BM, Partin MT, Humphreys EB, Han M, et al. An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011. BJU Int 2013; 111 (1): 22-9. 13. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of the prostate cancer staging nomograms (Partin tables) for the new millennium. Urology 2001; 58 (6): 843-8. 14. Moslehi M, Cheki M, Salehi-Marzijarani M, Amuchastegui T, Gholamrezanezhadet A. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer. Rev Esp Med Nucl Imagen Mol 2013; 32 (5): 286-9. 15. Lee N,  Fawaaz R,  Olsson CA,  Benson MC,  Petrylak DP, Schiff PB, et al . Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients. Int J Radiation Oncology Biol Phys 2000; 48 (5): 1443-6. 16. D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280 (11): 969- 74. 17. Levran Z, González JA, Diokno AC, Jafri SZ, Steinert BW. Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer? Br J Urol 1995; 75: 778-81. 18. Lavery HJ, Brajtbord JS, Levinson AW, Nabizada-Pace F, Pollard ME, Samadi DB. Unnecessary imaging for the staging of low-risk prostate cancer is common. Urology 2011; 77 (2): 274-8 19. Kindrick AV, Grossfeld GD, Stier DM, Flanders SC, Henning JM, Carroll PR. Use of imaging tests for staging newly diagnosed prostate cancer: trends from the CaPSURE database. J Urol 998; 160: 2102-6. 20. Cooperberg MR, Lubeck DP, Grossfeld GD, Mehta SS, Carroll PR. Contemporary trends in imaging test utilization for prostate cancer staging: data from the cáncer of the prostate strategic urologic research endeavor. J Urol 2002; 168: 491-5. 21. Lu-Yao GL, Friedman M, Yao SL. Use of radical prostatectomy among Medicare beneficiaries before and after the introduction of prostate specific antigen testing. J Urol 1997; 157 (6): 2219. Rev Med Chile 2017; 145: 579-584


Mayo_2017
To see the actual publication please follow the link above